Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR--an activator of AMP-activated protein kinase.
about
Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARKCharacterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cellsAMPK: a cellular metabolic and redox sensor. A minireviewMetabolic shifts during aging and pathologyAlteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulationMicroarrayed compound screening (microARCS) to identify activators and inhibitors of AMP-activated protein kinase.Neurologic aspects of adenylosuccinate lyase deficiency.Adenylosuccinate lyase deficiency.Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseasesDual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.Chronic ethanol consumption disrupts diurnal rhythms of hepatic glycogen metabolism in miceRegulation of glucose transport by the AMP-activated protein kinase.Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodelingThe AMPK β2 subunit is required for energy homeostasis during metabolic stressContraction signaling to glucose transport in skeletal muscle.Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise.AMPK alterations in cardiac physiology and pathology: enemy or ally?AMP-activated protein kinase and the regulation of glucose transport.AMP-activated protein kinase control of energy metabolism in the ischemic heart.Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.Points of integration between the intracellular energy sensor AMP-activated protein kinase (AMPK) activity and the somatotroph axis function.The multifaceted activities of AMPK in tumor progression--why the "one size fits all" definition does not fit at all?Regulation of glycogen breakdown and its consequences for skeletal muscle function after training.Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.Insulin Resistance and Mitochondrial Dysfunction.Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS).AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells.The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.KATP channel deficiency in mouse FDB causes an impairment of energy metabolism during fatigue.Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis.AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms.β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
P2860
Q24532696-28EC88CC-5FB9-4AEE-BD6E-350EB925FC3EQ24534051-AEEEFC97-ACA0-4E30-8250-2D9D53141DDFQ26995682-FC834703-F3AB-42C0-A696-F1F585F31452Q28088313-C09E99F5-0C26-4E51-A01C-1781DFE343A2Q28569545-22EB6F14-1053-413D-A4B7-A3B106B61861Q33199013-4DEE7119-B0A4-4081-AEF5-7D27B179F632Q34273778-EB93F107-CCF4-406E-AD9F-A604BF37D882Q34433219-ABA83027-654D-404C-9C29-F9ADD8968CFFQ35224775-1CB17F11-63C1-4F05-A86E-3DDAEB7A6A0DQ35613319-AC614528-BDD6-4D97-8780-F9CE25BE54FFQ35671809-D2E4C825-356C-4A29-9DDA-BEF932AEB528Q35855903-2E1D9F9F-B2F2-4538-A968-96CED8132DA8Q36091987-94525E37-62E5-42E1-88B5-DE43D38F771AQ36155100-8BE7FC5D-385E-4E1B-BAEF-D75CE7C4B07CQ36203847-54E76E16-D5A7-41CC-B576-9AE95B67C798Q36475851-375B5675-9D17-43FE-9740-DB7BC3C2CD68Q36475855-B5FD0B6A-497B-4953-B525-B3C35D43D279Q36528251-BB9C43C1-4089-433A-995D-AD9DF28C8DC6Q37249338-42B3981E-A3C3-49D4-BAA4-ADFC9C9232B0Q37454154-92C6A007-A77D-419D-A567-6AB549E292DBQ38021964-6AA5F3D0-3F62-4A5F-AE58-F776CA2CB07EQ38165133-6032C842-1802-491E-8EF4-FB5D695ED4EFQ38207879-793096C9-739E-473B-824C-1DB9241D28D9Q38947158-E9491986-E72C-4373-AAE3-9DEBDC626D94Q39133938-9B253CFA-6B1E-46ED-8414-EA59F0D47CE2Q39334553-B400DF80-86EC-4C35-82AA-991F21D57BA8Q39430006-6286D7F8-F45D-4CB0-876C-E675A5850BC7Q39611109-EC52A016-738E-4C52-B76B-2ED8ED5DF3ABQ39709119-70F75193-4D73-4195-9A5C-6BADBABF50AEQ40047094-5939D295-8BCE-4203-A996-20B81BA38FC0Q40109598-6353EB15-84AF-4042-87FF-15967FB9FA6BQ40998382-33A63148-EB46-498F-B2B7-91CCE1CD6E8FQ41630359-EBD9F29E-F23F-4E79-B955-52C7520C4E69Q41951897-63FE49DC-F819-4759-BD8A-5B16E580DE40Q42468549-C03E2EF5-2B51-40A4-8E50-4F76BA02E5DDQ42476103-424F34FA-6857-4669-94E4-939D4D2AD526Q43003369-DF8FDFF2-E734-4E2D-AF8F-FE289021F4CBQ44355191-E5ADE8BF-B8A4-4616-8284-318EF8804DADQ45306194-98DF19F1-08FE-483C-ABC5-D693434B77F1Q46620833-568CBA6C-7536-4472-88A7-D9C95153352D
P2860
Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR--an activator of AMP-activated protein kinase.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Activation of glycogen phospho ...... AMP-activated protein kinase.
@en
Activation of glycogen phospho ...... AMP-activated protein kinase.
@nl
type
label
Activation of glycogen phospho ...... AMP-activated protein kinase.
@en
Activation of glycogen phospho ...... AMP-activated protein kinase.
@nl
prefLabel
Activation of glycogen phospho ...... AMP-activated protein kinase.
@en
Activation of glycogen phospho ...... AMP-activated protein kinase.
@nl
P2093
P2860
P1433
P1476
Activation of glycogen phospho ...... AMP-activated protein kinase.
@en
P2093
P2860
P356
10.1016/0014-5793(96)00129-9
P407
P577
1996-03-01T00:00:00Z